Brunswick Corporation

BC

CIK 0000014930 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.33B
↑+15.5% +$179Mvs FY2024 (Q4)
Operating Income
$42M
Net Income
$19M
Gross Profit
$308M
↑+21.6% +$55Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
35/100
  • Profitability
    0ROIC -0.8% (10% = solid, 20%+ = moat)
  • Liquidity
    47Current Ratio 1.44 (above 1.5 = solid)
  • Leverage
    35D/E 1.30 (under 0.5 = conservative)
  • Efficiency
    60Asset Turnover 0.98x (1.0+ = capital-efficient)
  • Growth
    68Revenue YoY +15.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 3.1% · trend -9.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 26.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$200.58
Total enterprise IV
$13.22B
Diluted shares
0.07B
Terminal PV
$10.26B (78% of total)
Year-5 FCF
$1.21B
YearProjected FCFDiscounted PV
+1$495M$450M
+2$619M$512M
+3$774M$582M
+4$968M$661M
+5$1.21B$751M
Terminal$16.53B$10.26B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$166M
investment in PP&E
Dividends paid (TTM)
$113M
cash returned to holders
Stock buybacks (TTM)
$80M
share count reduction
Stock-based comp (TTM)
$39M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$5.31B
everything owned
Stockholders' equity
$1.63B
shareholder claim
Net debt
$1.86B
LT debt minus cash

Recent performance · 65 quarters

Revenue↑+15.5% +$179M
$1.33B
Net Income
$19M
Free Cash Flow↓-69.7% -$193M
$84M
Operating Margin
3.1%

Drill down